Overview

Stephen A. Mohr is an antitrust & competition partner in the Washington, D.C., office of Kirkland & Ellis LLP. Prior to joining Kirkland, Stephen served as Assistant Director in the Federal Trade Commission’s (FTC) Bureau of Competition, where he led the Mergers I Division. He oversaw merger investigations and led major litigations across a variety of industries, including pharmaceuticals, medical devices, pharmacies, PBMs, clinical laboratories, dialysis, next-generation medical technologies, veterinary clinics, healthcare advertising, defense, aviation, and consumer, industrial and life sciences products.

During his tenure as Assistant Director, he supervised all aspects of the Division’s merger investigations and enforcement actions. He has extensive courtroom experience and was involved in shaping the FTC’s merger enforcement program in recent years, including the development and prosecution of several of its most groundbreaking enforcement actions such as those involving innovation competition, the acquisition of nascent competitors by dominant firms, portfolio leveraging, serial acquisitions, vertical mergers and the litigation of behavioral remedies. Stephen also oversaw and negotiated complex consent agreements in various industries. He led the Division’s engagement with critical stakeholders, including the Department of Justice, the Department of Defense, the Food and Drug Administration (FDA), Congress, state attorneys general and foreign antitrust regulators.

He frequently speaks about antitrust issues related to pharmaceutical, medical device and life science mergers, and is a recipient of numerous FTC awards, including the prestigious Brandeis Award for outstanding litigators.

More

Thought Leadership

Publications

Author, “The Closest Competitor Is Not the Only Competitor,” FTC Competition Matters, 2019

Author, “Effective Presentation of Expert Testimony for the Government in a Merger Litigation,” Antitrust Magazine, Vol. 31, No.1, 2016

Speaking Engagements

“Navigating the New Merger Guidelines in Pharmaceuticals,” GCR Antitrust Conference, 2024

“Merger Developments,” Bill Kovacic Antitrust Salon Presented by Concurrences, 2024

“New Competition Theories in Life Sciences Mergers,” ABA Antitrust in Healthcare Law Conference, 2024

“Nascent and Potential Competition: Issues and Considerations,” Hal White Antitrust Conference, 2024

“Sanofi / Maze: An A-maze-ing Expansion of the Nascent Competition Doctrine?” ABA Antitrust Law Section Panel, 2024

“Just What the Doctor Ordered? FTC Treatment of Medical Device Mergers,” ABA Antitrust in Healthcare Law Conference, 2021

“Presenting Economic Evidence in Merger Trials,” 64th Antitrust Law ABA Spring Meeting Panel, 2017

“Identifying, Hiring, and Managing Experts,” ABA Be the Master Training Series, 2017

Recognition

Stephen is the recipient of numerous Federal Trade Commission honors, including in 2015, the Louis D. Brandeis Award, given annually to a single FTC attorney for outstanding service in litigation, numerous Janet Steiger Team Awards and the Distinguished Service Award.

Credentials

Admissions & Qualifications

  • District of Columbia

Courts

  • United States Court of Appeals for the District of Columbia Circuit
  • United States District Court for the Central District of California

Education

  • Harvard Law SchoolJ.D.magna cum laude2006
  • University of North Carolina at Chapel HillB.S., Business & Economics2003